CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Our comprehensive analysis of the activity of telomerase in CML CD34+ cells does not confirm earlier observations, which pointed to changes in the activity of this enzyme depending on the phase of disease in leukocyte cells of patients with CML (Ohyashiki et al. 1997).